Published in Breast Cancer Res on January 07, 2012
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 10.35
A mechanism linking extra centrosomes to chromosomal instability. Nature (2009) 9.45
Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet (2010) 7.62
Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19
BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques (2002) 5.98
The quantitative analysis of mammographic densities. Phys Med Biol (1994) 5.71
An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature (2004) 3.69
Genome-wide survey of protein kinases required for cell cycle progression. Nature (2004) 3.40
Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst (2010) 3.39
Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 2.81
The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.71
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev (2005) 2.28
The association of breast mitogens with mammographic densities. Br J Cancer (2002) 2.25
Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst (1997) 2.21
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst (2005) 2.16
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res (2000) 2.10
Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Am J Epidemiol (2008) 2.06
Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev (1996) 2.00
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77
A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat (2010) 1.54
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
A new measure of the effective number of tests, a practical tool for comparing families of non-independent significance tests. Genet Epidemiol (2009) 1.43
Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst (1992) 1.42
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.39
GLOSSI: a method to assess the association of genetic loci-sets with complex diseases. BMC Bioinformatics (2009) 1.38
Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res (2010) 1.36
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol (2009) 1.35
Illumina, Inc. Pharmacogenomics (2005) 1.35
Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res (2006) 1.29
Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res (2007) 1.26
Can genes for mammographic density inform cancer aetiology? Nat Rev Cancer (2008) 1.17
Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor. J Biol Chem (2008) 1.10
Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology (1995) 1.06
Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology (1978) 1.05
Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat (2011) 1.05
Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol (2011) 1.04
Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat (2010) 1.03
Mammographic density and epithelial histopathologic markers. BMC Cancer (2009) 1.00
Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat (1996) 1.00
Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev (2005) 0.98
Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res (2007) 0.95
Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat (2010) 0.94
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology (1990) 0.94
Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev (2007) 0.93
Alcohol intake in adolescence and mammographic density. Int J Cancer (2005) 0.90
The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast. Br J Radiol (1990) 0.90
The histopathology of mammographic patterns. Am J Clin Pathol (1978) 0.89
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat (2011) 0.89
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer. Breast Cancer Res (2010) 0.87
BeadArray-based solutions for enabling the promise of pharmacogenomics. Biotechniques (2005) 0.84
Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res (2007) 0.82
Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur Radiol (1997) 0.78
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med (2013) 13.92
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A (2005) 13.54
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet (2011) 8.57
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res (2006) 8.08
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell (2006) 7.33
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol (2005) 6.90
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Mobile phone use and the risk of acoustic neuroma. Epidemiology (2004) 6.04
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature (2008) 5.98
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet (2007) 5.17
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Breast-cancer risk in families with mutations in PALB2. N Engl J Med (2014) 4.97
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Progress in tuberculosis control and the evolving public-health system in China. Lancet (2007) 4.86
Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med (2015) 4.77
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet (2007) 4.69
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet (2004) 4.61
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat (2006) 4.35
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol (2009) 4.13
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Origins and genetic legacy of Neolithic farmers and hunter-gatherers in Europe. Science (2012) 3.82
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Long-term mobile phone use and brain tumor risk. Am J Epidemiol (2005) 3.80
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet (2007) 3.63
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet (2011) 3.46
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42